Evidence map›Paper›PMID 34883311›Full record

ArticleSocial science & medicine (1982)2022

"Please, you go first!" preferences for a COVID-19 vaccine among adults in the Netherlands.

Niek Mouter, Annamarie de Ruijter, G Ardine de Wit, Mattijs S Lambooij, Maarten van Wijhe, Job van Exel, Roselinde Kessels

Abstract read
In one paragraph

Article in Social science & medicine (1982), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Which factors drive the choice of the French-speaking Quebec population towards a COVID-19 vaccination programme: A discrete-choice experiment.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cognitive underpinnings of COVID-19 vaccine hesitancy.Social science & medicine (1982) · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Niek MouterDelft University of Technology, Faculty of Technology, Policy and Management, Transport and Logistics Group, Jaffalaan 5, 2628 BX, Delft, the Netherlands. Electronic address: n.mouter@tudelft.nl.
Annamarie de RuijterDelft University of Technology, Faculty of Technology, Policy and Management, Transport and Logistics Group, Jaffalaan 5, 2628 BX, Delft, the Netherlands.
G Ardine de WitNational Institute of Public Health and the Environment, Center for Nutrition, Prevention and Healthcare, Bilthoven, the Netherlands; Utrecht University, University Medical Center Utrecht, Juliuscenter for Health Sciences and Primary Care, Utrecht University, Utrecht, the Netherlands.
Mattijs S LambooijNational Institute of Public Health and the Environment, Center for Nutrition, Prevention and Healthcare, Bilthoven, the Netherlands.
Maarten van WijheRoskilde University, PandemiX Center, Department of Science and Environment Universitetsvej 1, 4000, Roskilde, Denmark.
Job van ExelErasmus University Rotterdam Erasmus School of Health Policy & Management, the Netherlands.
Roselinde KesselsMaastricht University, Department of Data Analytics and Digitalization, PO Box 616, 6200 MD, Maastricht, the Netherlands; University of Antwerp, Department of Economics, City Campus, Prinsstraat 13, B-2000 Antwerp, Belgium. Electronic address: r.kessels@maastrichtuniversity.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVaccination is generally considered the most direct way to restoring normal life after the outbreak of COVID-19, but the available COVID-19 vaccines are simultaneously embraced and dismissed. Mapping factors for vaccine hesitancy may help the roll-out of COVID-19 vaccines and provide valuable insights for future pandemics.

objectivesWe investigate how characteristics of a COVID-19 vaccine affect the preferences of adult citizens in the Netherlands to take the vaccine directly, to refuse it outright, or to wait a few months and first look at the experiences of others.

methodsAn online sample of 895 respondents participated between November 4th and November 10th, 2020 in a discrete choice experiment including the attributes: percentage of vaccinated individuals protected against COVID-19, month in which the vaccine would become available and the number of cases of mild and severe side effects. The data was analysed by means of panel mixed logit models.

resultsRespondents found it important that a safe and effective COVID-19 vaccine becomes available as soon as possible. However, the majority did not want to be the first in line and would rather wait for the experiences of others. The predicted uptake of a vaccine with the optimal combination of attributes was 87%, of whom 55% preferred to take the vaccine after a waiting period. This latter group tends to be lower-educated. Older respondents gave more weight to vaccine effectiveness than younger respondents.

conclusionsThe willingness to take a COVID-19 vaccine is high among adults in the Netherlands, but a considerable proportion prefers to delay their decision to vaccinate until experiences of others are known. Offering this wait-and-see group the opportunity to accept the invitation at a later moment may stimulate vaccination uptake. Our results further suggest that vaccination campaigns targeted at older citizens should focus on the effectiveness of the vaccine.

Indexed as

COVID-19COVID-19 VaccinesAdultHumansNetherlandsSARS-CoV-2VaccinationVaccination HesitancyVaccine EfficacyCOVID-19 VaccinesCOVID-19Discrete choice experimentHealth policyPublic preferencesSARS-CoV-2Vaccination

Identifiers

PMID34883311
PMCPMC8636308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.